Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001005477-98-000701
Filing Date
1998-03-10
Accepted
1998-03-10 00:00:00
Documents
6
Period of Report
1997-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K 304402
2 LICENSE AGREEMENT EX-10.51 228328
3 COMPUTATION OF NET LOSS PER COMMON SHARE EX-11.1 2359
4 CONSENT OF INDEPENDENT ACCOUNTANTS EX-23.1 592
5 POWER OF ATTORNEY EX-24.1 193
6 FINANCIAL DATA SCHEDULE EX-27 2511
  Complete submission text file 0001005477-98-000701.txt   540380
Mailing Address 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM NC 27707
Business Address 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM NC 27707 9194935980
TRIANGLE PHARMACEUTICALS INC (Filer) CIK: 0001022622 (see all company filings)

EIN.: 561930728 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21589 | Film No.: 98560730
SIC: 2834 Pharmaceutical Preparations